THE NEXT GENERATION OF BIOPHARMA LEADERS

There are about 200 major pharmaceutical companies in the world, and some of them are helmed by dynamic CEOs who have turned the fortunes of the companies around, invested in pathbreaking research and expanded their companies’ reach with mergers and acquisitions in line with their expertise.

-  Christy Gren

The Covid-19 pandemic of 2020 has thrust the pharmaceutical and biotech industry centerstage with almost all the major players in the industry engaged in coming up with a solution to the Coronavirus pandemic. There are about 200 major pharmaceutical companies in the world, and some of them are helmed by dynamic CEOs who have turned the fortunes of the companies around, invested in pathbreaking research and expanded their companies’ reach with mergers and acquisitions in line with their expertise.

Here we bring you the top 10 biotech industry leaders.

JOHN CRAWLEY

Amicus Therapeutics

New Jersey

John Crawley has been with Amicus Therapeutics for over 15 years and has seen the company grow from just four people to employing over 500 people. He has risen with the company to become its chairman and chief executive officer. Amicus now has a presence in over 27 countries. Crawley became involved with the biotech business after his two children were diagnosed with the Pompe disease, a fatal neuromuscular disorder.

He started looking for a cure for the disease and left his position as director at Bristol-Myers Squibb. He started Novazyme Pharmaceuticals with a friend, dedicated to research and development for Pompe disease. He was successful in his mission to save his children after coming up with a cure.

His life journey has been chronicled by Pulitzer prize-winning journalist Geeta Anand in her book, The Cure: How a Father Raised $100 Million-And Bucked the Medical Establishment-In a Quest to Save His Children. The major motion picture, Extraordinary Measures, is also inspired by his story.